Cargando…

Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer

Better biomarkers are needed to improve the efficacy of immune checkpoint inhibitors in lung adenocarcinoma (LUAD) treatment. We investigated the plasma extracellular vesicle (EV)‐derived long RNAs (exLRs) in unresectable/advanced LUAD to explore biomarkers for immunochemotherapy. Seventy‐four LUAD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Jiatao, Lai, Hongyan, Liu, Chang, Zhang, Xin, Ou, Qiuxiang, Li, Qiaojuan, Li, Yan, Wang, Zhen, Liu, Cuicui, Wu, Xianghua, Wang, Huijie, Yu, Hui, Sun, Si, Zhao, Xinmin, Hu, Zhihuang, Zhang, Yao, Lin, Ying, Yu, Bo, Huang, Shenglin, Wang, Jialei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323081/ https://www.ncbi.nlm.nih.gov/pubmed/37014183 http://dx.doi.org/10.1111/cas.15804

Ejemplares similares

Plasma Extracellular Vesicle Long RNA in Diagnosis and Prediction in Small Cell Lung Cancer
por: Liu, Chang, et al.
Publicado: (2022)

A phase II study of anlotinib combined with etoposide and platinum‐based regimens in the first‐line treatment of extensive‐stage small cell lung cancer
por: Liu, Chang, et al.
Publicado: (2022)

Prognostic value of hematologic parameters in advanced non-small cell lung cancer patients receiving anti-PD-1 inhibitors
por: Zhao, Xinmin, et al.
Publicado: (2022)

Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II Study
por: Hu, Zhihuang, et al.
Publicado: (2022)

Direct Comparison Between the Addition of Pembrolizumab or Bevacizumab for Chemotherapy-Based First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer Lacking Driver Mutations
por: Liao, Jiatao, et al.
Publicado: (2021)

exoRBase 2.0: an atlas of mRNA, lncRNA and circRNA in extracellular vesicles from human biofluids
por: Lai, Hongyan, et al.
Publicado: (2021)

Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor
por: Lin, Ying, et al.
Publicado: (2023)

Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA
por: Zhao, Xinmin, et al.
Publicado: (2023)

Correction to: Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA
por: Zhao, Xinmin, et al.
Publicado: (2023)

The optimal timing and courses of bevacizumab added to chemotherapy for non-squamous non-small cell lung cancer: revelations from the real-world experience in a single Chinese cancer center
por: Long, Qianqian, et al.
Publicado: (2020)

Hormone receptor expression correlates with EGFR gene mutation in lung cancer in patients with simultaneous primary breast cancer
por: Hu, Zhihuang, et al.
Publicado: (2020)

Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors
por: Sun, Si, et al.
Publicado: (2017)

Efficacy and safety of first-line pemetrexed plus carboplatin followed by single-agent pemetrexed maintenance in elderly Chinese patients with non-squamous non-small-cell lung cancer
por: Zhao, Xinmin, et al.
Publicado: (2017)

EV-origin: Enumerating the tissue-cellular origin of circulating extracellular vesicles using exLR profile
por: Li, Yuchen, et al.
Publicado: (2020)

Extracellular Vesicles and Autophagy in Osteoarthritis
por: Gao, Tianyang, et al.
Publicado: (2016)

An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy
por: Chen, Yichao, et al.
Publicado: (2016)

Current trends of anticancer immunochemotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Hypofractionated radiotherapy with immunochemotherapy for extensive-stage small-cell lung cancer
por: Liu, Chaoyuan, et al.
Publicado: (2023)

Macrophage-derived small extracellular vesicles promote biomimetic mineralized collagen-mediated endogenous bone regeneration
por: Liu, Anqi, et al.
Publicado: (2020)

miR160: An Indispensable Regulator in Plant
por: Hao, Kai, et al.
Publicado: (2022)

Targeted delivery of extracellular vesicles in heart injury
por: Chen, Peier, et al.
Publicado: (2021)

Plasma extracellular vesicle long RNA profiles in the diagnosis and prediction of treatment response for breast cancer
por: Su, Yonghui, et al.
Publicado: (2021)

Trial Watch: Lenalidomide-based immunochemotherapy
por: Semeraro, Michaela, et al.
Publicado: (2013)

Immunochemotherapy for Richter syndrome: current insights
por: Puła, Bartosz, et al.
Publicado: (2019)

Immunotherapy and immunochemotherapy in combating visceral leishmaniasis
por: Yadagiri, Ganesh, et al.
Publicado: (2023)

Bifidobacterium in anticancer immunochemotherapy: friend or foe?
por: Procaccianti, Giorgia, et al.
Publicado: (2023)

KIBRA regulates amyloid β metabolism by controlling extracellular vesicles secretion
por: Han, Xiaolei, et al.
Publicado: (2022)

Delta-radiomics based on CT predicts pathologic complete response in ESCC treated with neoadjuvant immunochemotherapy and surgery
por: Li, Kaiyuan, et al.
Publicado: (2023)

A Phase II Study of Gemcitabine, Vincristine, and Cisplatin (Gvp) As Second-Line Treatment for Patients with Advanced Soft Tissue Sarcoma
por: Luo, Zhiguo, et al.
Publicado: (2015)

A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer
por: Liu, Xin, et al.
Publicado: (2017)

Nucleoporin 160 (NUP160) inhibition alleviates diabetic nephropathy by activating autophagy
por: Xie, Jiayong, et al.
Publicado: (2021)

Trends in the biological functions and medical applications of extracellular vesicles and analogues
por: Zhao, Yan, et al.
Publicado: (2021)

Author Correction: Plasma extracellular vesicle long RNA profiles in the diagnosis and prediction of treatment response for breast cancer
por: Su, Yonghui, et al.
Publicado: (2022)

Case Report: EGFR-Positive Early-Stage Lung Adenocarcinoma Transforming to Squamous Cell Carcinoma After TKI Treatment
por: Liao, Jiatao, et al.
Publicado: (2021)

In situ injectable hydrogel-loaded drugs induce anti-tumor immune responses in melanoma immunochemotherapy
por: Li, Jiehan, et al.
Publicado: (2022)

Evaluation of the cargo contents and potential role of extracellular vesicles in osteoporosis
por: Xu, Jifeng, et al.
Publicado: (2021)

Extracellular Vesicles for Drug Delivery in Cancer Treatment
por: Wang, Li, et al.
Publicado: (2023)

Expanding the role of combined immunochemotherapy and immunoradiotherapy in the management of head and neck cancer (Review)
por: Wei, Chun, et al.
Publicado: (2023)

BBBBB160 /
por: Kozer, José
Publicado: (2013)

Inorganic Nanozyme with Combined Self-Oxygenation/Degradable Capabilities for Sensitized Cancer Immunochemotherapy
por: Wang, Jie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0tcbq3196fn6j09iblfln2hr0h